NDC 68180-202

SUPRAX

Cefixime

SUPRAX is a Oral Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Cefixime.

• Product ID: 68180-202_350b6e57-09ca-48c7-9bc5-0579403e981a
• NDC: 68180-202
• Product Type: Human Prescription Drug
• Proprietary Name: SUPRAX
• Generic Name: Cefixime
• Dosage Form: Powder, For Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2004-03-01
• Marketing Category: ANDA / ANDA
• Application Number: ANDA065129
• Labeler Name: Lupin Pharmaceuticals, Inc.
• Substance Name: CEFIXIME
• Active Ingredient Strength: 100 mg/5mL
• Pharm Classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 68180-202-01

100 mL in 1 BOTTLE (68180-202-01)

• Marketing Start Date: 2004-03-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 68180-202-04 [68180020204]

SUPRAX POWDER, FOR SUSPENSION

• Marketing Category: ANDA
• Application Number: ANDA065129
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-09-08

NDC 68180-202-01 [68180020201]

SUPRAX POWDER, FOR SUSPENSION

• Marketing Category: ANDA
• Application Number: ANDA065129
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2004-03-01

NDC 68180-202-05 [68180020205]

SUPRAX POWDER, FOR SUSPENSION

• Marketing Category: ANDA
• Application Number: ANDA065129
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2004-03-01

NDC 68180-202-02 [68180020202]

SUPRAX POWDER, FOR SUSPENSION

• Marketing Category: ANDA
• Application Number: ANDA065129
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2004-03-01

NDC 68180-202-03 [68180020203]

SUPRAX POWDER, FOR SUSPENSION

• Marketing Category: ANDA
• Application Number: ANDA065129
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2004-03-01

Drug Details

Active Ingredients

Ingredient	Strength
CEFIXIME	100 mg/5mL

OpenFDA Data

• SPL SET ID: 7e2462b2-bfed-4da4-8c47-46838d6153f8
• Manufacturer:
  • Lupin Pharmaceuticals, Inc.
• UNII:
  • 97I1C92E55
• RxNorm Concept Unique ID - RxCUI:
  • 309058
  • 581574
• UPC Code:
  • 0368180202035
  • 0368180202042

Pharmacological Class

• Cephalosporin Antibacterial [EPC]
• Cephalosporins [CS]

Medicade Reported Pricing

68180020203 SUPRAX 100 MG/5 ML SUSPENSION

Pricing Unit: ML | Drug Type:

NDC Crossover Matching brand name "SUPRAX" or generic name "Cefixime"

NDC	Brand Name	Generic Name
27437-201	SUPRAX	cefixime
27437-203	SUPRAX	cefixime
27437-205	SUPRAX	cefixime
27437-206	SUPRAX	cefixime
27437-207	SUPRAX	cefixime
27437-208	SUPRAX	cefixime
43063-537	SUPRAX	cefixime
54348-797	SUPRAX	CEFIXIME
68180-202	SUPRAX	SUPRAX
70518-1020	SUPRAX	SUPRAX
70934-079	SUPRAX	SUPRAX
70518-2006	SUPRAX	SUPRAX
16714-766	Cefixime	cefixime
16714-767	Cefixime	cefixime
43598-673	Cefixime	Cefixime
43598-674	Cefixime	Cefixime
62250-663	Cefixime	cefixime
62250-664	Cefixime	cefixime